PLS, UWL, NEU, AVR, HXL: 5 ASX stocks with over 100% past year gains

Image Source: Copyright © 2021 Kalkine Media

Highlights 

  • Despite the ASX 200 trading on an uncertain note in the recent past, some stocks have given over 100% past year returns.
  • The stocks with over 100% returns are called multibaggers stocks.
  • PLS, UWL, NEU, AVR, and HXL are few stocks which can be looked at.

 

Even as ASX 200 has remained volatile in the past few months, there are stocks which have delivered over 100% past year returns to their shareholders. The stocks with over 100% returns are called multibaggers stocks. While most of these stocks come up with robust fundamentals, these are generally undervalued. Multibagger stocks generally have low prices. On this note, let’s discuss five ASX-listed stocks with over 100% past year returns:

Pilbara Minerals Ltd (ASX:PLS)

Pilbara Minerals is a producer and explorer of lithium and tantalum. The company’s primary project is the Pilgangoora Operation, situated in Western Australia.

In the past one year, the stock has delivered a return of over 180% (as on 16 February 2021).  However, the stock has fallen over 13% year-to-date (YTD). The 52-week high and low of the stock stand at AU$3.89 and AU$0.88, respectively.

In the December quarter, the company reported record operating cash flow on account of rising lithium prices despite negative impact on production from plant commissioning, ramp-up delays and labour shortages.

Neuren Pharmaceuticals Ltd (ASX:NEU)

Neuren specialises in neurological conditions. The biopharmaceutical company is currently developing new drug therapies for neurological disorders.

In the past one year, the stock has delivered a return of over 190%.  However, the stock has fallen over 4% year-to-date (YTD). The 52-week high and low of the stock stand at AU$4.49 and AU$1.20, respectively.

According to the latest released activity report for the quarter ended 31 December 2021, Neuren said that it expects to receive revenue worth AU$111 million over 2022 and 2023 for Rett syndrome, in US.

Source: © Kiosea39   | Megapixl.com

Anteris Technologies Ltd (ASX:AVR)

Anteris provides innovative healthcare solutions. It develops, invests, and delivers leading edge medical technologies.

In the past one year, the stock has delivered a return of over 330%.  However, the stock has fallen nearly 70% year-to-date (YTD). The 52-week high and low of the stock stand at AU$22.61 and AU$5, respectively.

Last month, AVR reported successful results for the first human trial of DurAVR™.

Carnaby Resources Ltd (ASX:CNB)

Carnaby Resources is a mineral exploration company established with the purpose of acquiring, exploring, and developing gold, cobalt, diamond, and other mineral deposits.

In the past one year, the stock has delivered a return of over 500%.  However, the stock’s year-to-date (YTD) return stands at a negative 7%. The 52-week high and low of the stock stand at AU$2.20 and AU$0.21, respectively.

Earlier this month, Carnaby Resources reported a major copper gold discovery at its Nil Desperandum Prospect, within the Greater Duchess Copper Gold Project, situated in Queensland.

Hexima Ltd (ASX:HXL)

Hexima is a biotechnology company. It is engaged in the research and development of anti-infectives.

In the past one year, the stock has delivered a return of over 153%.  However, the stock has dropped over 7% year-to-date (YTD). The 52-week high and low of the stock stand at AU$0.50 and AU$0.14, respectively.

The biotech firm reported cash and cash equivalent of AU$12.1 million in the quarter ended 31 December 2021. Hexima also completed an AU$10 million institutional placement in the same quarter.

Hexima is a penny stock and investors need to research before taking any exposure in such stocks due to their high-risk nature.

RELATED ARTICLE: SLR, NST and EVN – Three ASX gold stocks catching investors’ attention

RELATED ARTICLE: Three ASX healthcare stocks under AU$5 with over 4% dividend

RELATED ARTICLE: BTT, SHIB & XEC: Top 3 cheap cryptocurrencies with market cap over $1B


 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and